Abstract
Purpose
Simvastatin (SIM), a HMG-CoA reductase inhibitor widely prescribed for hypercholesterolemia, has been reported to ameliorate inflammation and promote osteogenesis. Its clinical applications on these potential secondary indications, however, have been hampered by its lack of osteotropicity and poor water solubility. To address this challenge, we propose to design and evaluate the therapeutic efficacy of a novel simvastatin prodrug with better water solubility and bone affinity.
Method
The prodrug (SIM-PPi) was synthesized by directly conjugating a SIM trimer to a pyrophosphate (PPi). It was characterized and evaluated in vitro for its water solubility, osteotropicity, toxicity, anti-inflammatory and osteoinductive properties. It was then tested for anti-inflammatory and osteoinductive properties in vivo by three weekly injections into gingiva of a ligature-induced experimental periodontitis rat model.
Results
In vitro studies showed that SIM-PPi has greatly improved water-solubility of SIM and shows strong binding to hydroxyapatite (HA). In macrophage culture, SIM-PPi inhibited LPS-induced pro-inflammatory cytokines (IL-1β, IL-6). In osteoblast culture, it was found to significantly increase alkaline phosphatase (ALP) activity with accelerated mineral deposition, confirming the osteogenic potential of SIM-PPi. When tested in vivo on an experimental periodontal bone-loss model, SIM-PPi exhibited a superior prophylactic effect compared to dose equivalent SIM in reducing inflammatory cells and in preserving alveolar bone structure, as shown in the histological and micro-CT data.
Conclusion
SIM-PPi may have the potential to be further developed for better clinical management of bone loss associated with periodontitis.
Similar content being viewed by others
Abbreviations
- ABC:
-
Alveolar bone crest
- ALP:
-
Alkaline phosphatase
- BMP-2 :
-
Bone morphogenetic protein-2
- CEJ:
-
Cementoenamel junction
- EDTA:
-
Ethylenediaminetetraacetic acid
- GCF:
-
Gingival crevicular fluid
- HA:
-
Hydroxyapatite
- HMG-CoA:
-
3-Hydroxy-3-methyl-glutaryl-coenzyme A
- LPS:
-
Lipopolysaccharide
- M1:
-
First molar
- M2:
-
Second molar
- MCP-1 :
-
Monocyte chemoattractant protein-1
- MMPs:
-
Matrix metalloproteinases
- MTT:
-
3-(4,5-Dimethyl- thiazol-2yl)-2,5- diphenyltetrazoliumbromide
- OPG:
-
Osteoprotegerin
- PPi:
-
Pyrophosphate
- RANK:
-
Receptor activator of nuclear factor-kappa B
- RANKL:
-
Receptor activator of nuclear factor-kappa B ligand
- ROI:
-
Region of interest
- SIM:
-
Simvastatin
- SIM-PPi:
-
Simvastatin-pyrophosphate
- Tb.N:
-
Trabecular number
- Tb.Sp:
-
Trabecular spacing or separation
- Tb.Th:
-
Trabecular thickness
- μ-CT:
-
Micro-computed tomography
References
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet [Internet]. 2005 Nov 19 [cited 2017 Nov 6];366(9499):1809–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16298220.
Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, et al. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol [Internet]. 2015 May [cited 2017 Dec 22];86(5):611–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25688694.
Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol [Internet]. 2014;15(1):30–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25534621.
Krayer JW, Leite RS, Kirkwood KL. Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases. Dent Clin North Am [Internet]. 2010 Jan [cited 2017 Aug 23];54(1):13–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20103470.
Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol [Internet]. 2002 [cited 2017 Aug 23];29 Suppl 3:136–59; discussion 160–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12787214.
Greenstein G. Local drug delivery in the treatment of periodontal diseases: assessing the clinical significance of the results. J Periodontol [Internet]. 2006 Apr [cited 2017 Aug 23];77(4):565–78. Available from: https://doi.org/10.1902/jop.2006.050140.
Williams RC, Jeffcoat MK, Howell TH, Reddy MS, Johnson HG, Hall CM, et al. Ibuprofen: An inhibitor of alveolar bone resorption in beagles. J Periodontal Res [Internet]. 1988 Jul 1 [cited 2017 Aug 23];23(4):225–9. Available from: https://doi.org/10.1111/j.1600-0765.1988.tb01363.x.
Raja S, Byakod G, Pudakalkatti P. Growth factors in periodontal regeneration. Int J Dent Hyg [Internet]. 2009 May [cited 2017 Aug 23];7(2):82–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19413545.
Bellosta S, Bernini F, Ferri N, Quarato P, Canavesi M, Arnaboldi L, et al. Direct vascular effects of HMG-CoA reductase inhibitors. Atherosclerosis [Internet]. 1998 Apr [cited 2017 Aug 23];137 Suppl:S101–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9694549.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science [Internet]. 1999;286(5446):1946–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10583956.
Garrett IR, Mundy GR. The role of statins as potential targets for bone formation. Arthritis Res [Internet]. 2002 [cited 2017 Aug 23];4(4):237. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12106493.
Emani S, Gunjiganur G, Mehta D. Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: an in vitro study. Contemp Clin Dent [Internet]. 2014 Jul [cited 2017 Apr 27];5(3):377. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25191077.
Lazzerini PE, Lorenzini S, Selvi E, Capecchi PL, Chindamo D, Bisogno S, et al. Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1??-stimulated synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol. 2007;25(5):696–700.
Pereira MC, Cardoso PRG, Da Rocha LF, Rêgo MJBM, Gonçalves SMC, Santos FA, et al. Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis. Inflamm Res. 2014;63(4):309–15.
Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin Use and Tooth Loss in Chronic Periodontitis Patients. J Periodontol [Internet]. 2006 Jun [cited 2017 Nov 5];77(6):1061–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16734582.
Pradeep AR, Thorat MS. Clinical Effect of Subgingivally Delivered Simvastatin in the Treatment of Patients With Chronic Periodontitis: A Randomized Clinical Trial. J Periodontol [Internet]. 2010 Feb [cited 2017 Nov 6];81(2):214–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20151799.
Agarwal S, Chaubey K, Chaubey A, Agarwal V, Madan E, Agarwal M. Clinical efficacy of subgingivally delivered simvastatin gel in chronic periodontitis patients. J Indian Soc Periodontol [Internet]. 2016 [cited 2018 May 25];20(4):409. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28298823.
Priyanka N, Abhilash A, Saquib S, Malgaonkar N, Kudyar N, Gupta A, et al. Clinical efficacy of Subgingivally delivered 1.2 mg simvastatin in the treatment of patients with aggressive periodontitis: a randomized controlled clinical trial. Int J Periodontics Restorative Dent [Internet]. [cited 2018 May 25];37(2):e135–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28196160.
Akram Z, Vohra F, Javed F. Efficacy of statin delivery as an adjunct to scaling and root planing in the treatment of chronic periodontitis: a meta-analysis. J Investig Clin Dent [Internet]. 2018 May [cited 2018 May 25];9(2):e12304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29119729.
Bradley AD, Zhang Y, Jia Z, Zhao G, Wang X, Pranke L, et al. Effect of Simvastatin Prodrug on Experimental Periodontitis. J Periodontol [Internet]. 2016 May [cited 2017 Apr 2];87(5):577–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26799395.
Price U, Le HOT, Powell SE, Schmid MJ, Marx DB, Zhang Y, et al. Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss. J Periodontal Res. 2013;48(5):541–8.
He Y, Ho C, Yang D, Chen J, Orton E. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts. J Pharm Sci [Internet]. 2017 May [cited 2018 Jan 15];106(5):1190–6. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0022354917300266.
Serajuddin AT, Ranadive SA, Mahoney EM. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin. J Pharm Sci [Internet]. 1991 Sep [cited 2018 Jan 17];80(9):830–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1800703.
Taha EA, Youssef NF. Spectrophotometric determination of some drugs for osteoporosis. Chem Pharm Bull (Tokyo) [Internet] 2003 Dec [cited 2018 May 25];51(12):1444–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14646329.
Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem [Internet]. 2004 Jun 1 [cited 2017 Nov 16];329(1):77–84. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0003269704001332.
Stein D, Lee Y, Schmid MJ, Killpack B, Genrich MA, Narayana N, et al. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol [Internet]. 2005 Nov [cited 2018 Jun 1];76(11):1861–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16274305.
Lee Y, Schmid MJ, Marx DB, Beatty MW, Cullen DM, Collins ME, et al. The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials [Internet]. 2008 Apr [cited 2018 Jun 1];29(12):1940–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18255137.
Nunes NLT, Messora MR, Oliveira LF, Lisboa M, Barcellos Garcia MC, Rêgo ROCC, et al. Effects of Local Administration of Tiludronic Acid on Experimental Periodontitis in Diabetic Rats. J Periodontol [Internet]. 2017 Sep 15 [cited 2018 May 25];1–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28914593.
Camacho-Alonso F, Davia-Peña RS, Vilaplana-Vivo C, Tudela-Mulero MR, Merino JJ, Martínez-Beneyto Y. Synergistic effect of photodynamic therapy and alendronate on alveolar bone loss in rats with ligature-induced periodontitis. J Periodontal Res [Internet]. 2018 Jun [cited 2018 May 25];53(3):306–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29086417.
Wada-Mihara C, Seto H, Ohba H, Tokunaga K, Kido J, Nagata T, et al. Local administration of calcitonin inhibits alveolar bone loss in an experimental periodontitis in rats. Biomed Pharmacother [Internet]. 2018 Jan [cited 2018 May 25];97:765–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29107933.
Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol [Internet]. 2013 Nov 4 [cited 2018 May 23];50(6):1007–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23558974.
Schett G, Stolina M, Bolon B, Middleton S, Adlam M, Brown H, et al. Analysis of the Kinetics of Osteoclastogenesis in Arthritic Rats. ARTHRITIS Rheum [Internet]. 2005 [cited 2018 May 25];52(10):3192–201. Available from: https://doi.org/10.1002/art.21343.
Bolon B, Morony S, Cheng Y, Hu Y-L, Feige U. Osteoclast Numbers in Lewis Rats with Adjuvant-induced Arthritis: Identification of Preferred Sites and Parameters for Rapid Quantitative Analysis 1. Vet Pathol [Internet]. 2004 [cited 2018 May 25];41:30–6. Available from: https://doi.org/10.1354/vp.41-1-30.
Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan N, Khojasteh A, Mashhadi-Abbas F, Eslami B, et al. Effect of Simvastatin Administration on Periodontitis-Associated Bone Loss in Ovariectomized Rats. J Periodontol [Internet]. 2007 Aug [cited 2017 Nov 6];78(8):1561–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17668976.
Xu X-C, Chen H, Zhang X, Zhai Z-J, Liu X-Q, Qin A, et al. Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy. J Transl Med [Internet]. 2014;12:284. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4192445&tool=pmcentrez&rendertype=abstract.
Elavarasu S, Suthanthiran TK, Naveen D. Statins: a new era in local drug delivery. J Pharm Bioallied Sci [Internet]. 2012 Aug [cited 2017 Nov 6];4(Suppl 2):S248–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23066263.
Durie BGM, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med [Internet]. 2005 Jul 7 [cited 2017 Nov 6];353(1):99–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16000365.
Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc [Internet]. 2009 Jul [cited 2017 Nov 6];84(7):632–7; quiz 638. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19567717.
Shellis RP, Addy M, Rees GD. In vitro studies on the effect of sodium tripolyphosphate on the interactions of stain and salivary protein with hydroxyapatite. J Dent [Internet]. 2005 Apr [cited 2017 Nov 6];33(4):313–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15781139.
Hefferren JJ. Historical view of dentifrice functionality methods. J Clin Dent [Internet]. 1998 [cited 2017 Nov 6];9(3):53–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10518861.
Joiner A. Whitening toothpastes: A review of the literature. J Dent [Internet]. 2010 Jan [cited 2017 Nov 6];38:e17–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20562012.
Yankell SL, Emling RC, Petrone ME, Rustogi K, Volpe AR, DeVizio W, et al. A six-week clinical efficacy study of four commercially available dentifrices for the removal of extrinsic tooth stain. J Clin Dent [Internet]. 1999 [cited 2017 Nov 6];10(3 Spec No):115–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10825858.
Yucel-Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med [Internet]. 2013;15(August):e7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23915822.
Pagkalos J, Cha JM, Kang Y, Heliotis M, Tsiridis E, Mantalaris A. Simvastatin induces osteogenic differentiation of murine embryonic stem cells. J Bone Miner Res [Internet]. 2010 Nov [cited 2017 Nov 16];25(11):2470–8. Available from: https://doi.org/10.1002/jbmr.163.
ACKNOWLEDGMENTS AND DISCLOSURES
This work was financially supported in part by the University of Nebraska Medical Center College of Pharmacy. Yosif Almoshari was supported by the Ministry of Education Scholarship, Jazan University (Jazan, Saudi Arabia). DW, RAR, XBW and ZSJ are co-inventors of a patent application of the SIM-PPi prodrug technology. The other authors report no conflicts of interest related to this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, X., Jia, Z., Almoshari, Y. et al. Local Application of Pyrophosphorylated Simvastatin Prevents Experimental Periodontitis. Pharm Res 35, 164 (2018). https://doi.org/10.1007/s11095-018-2444-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-018-2444-z